(VIANEWS) - Yesterday, the Innrs artificial intelligence algorithm suggested a few financial assets that would make investors a profit today.
Via News is daily fact-checking an AI algorithm that aims to predict financial assets' next session's price and next week's trend.
Innrs provides AI-based statistical tools to help investors make decisions.
If you had invested in last session's Innrs AI prediction, you would have a ROI of -0.85%.
| Financial Asset | Accuracy | Previous Close | Prediction | Close Price | ROI |
|---|---|---|---|---|---|
| Exelon (EXC) | 88.38% | $41.75 | $42.8 | $42.87 | 2.68% ✅ |
| VALE (VALE) | 88.62% | $16.43 | $16.72 | $16.76 | 2.01% ✅ |
| White Mountains Insurance Group (WTM) | 87.97% | $1303.87 | $1343.41 | $1316.21 | 0.95% ✅ |
| Public Service Enterprise Group (PEG) | 88.26% | $60.28 | $61.77 | $60.6 | 0.53% ✅ |
| Astrazeneca (AZN) | 94.05% | $68.44 | $70.14 | $68.56 | 0.18% ✅ |
| Gilead Sciences (GILD) | 88.6% | $87.89 | $89.14 | $87.96 | 0.08% ✅ |
| Church & Dwight Company (CHD) | 93.23% | $80.38 | $83.25 | $80.44 | 0.07% ✅ |
| NextEra Energy (NEE) | 88.37% | $85.23 | $87.14 | $85.18 | -0.06% |
| TJX Companies (TJX) | 89.34% | $79.43 | $81.71 | $79.36 | -0.09% |
| Coca-Cola (KO) | 93.7% | $63.51 | $64.87 | $63.44 | -0.11% |
| Eli Lilly and Company (LLY) | 94.35% | $369.4 | $377.09 | $368.54 | -0.23% |
| Booking Holdings (BKNG) | 93.5% | $2053.03 | $2068.68 | $2042.19 | -0.53% |
| Ross Stores (ROST) | 88.62% | $117.21 | $121.95 | $116.53 | -0.58% |
| Boston Scientific (BSX) | 89.23% | $45.44 | $45.89 | $45.16 | -0.62% |
| Amicus Therapeutics (FOLD) | 88.62% | $12.34 | $12.4 | $12.25 | -0.73% |
| Merck (MRK) | 98.27% | $109.78 | $112.48 | $108.93 | -0.77% |
| Stryker Corp (SYK) | 88.24% | $238.09 | $243.23 | $235.54 | -1.07% |
| Regeneron Pharmaceuticals (REGN) | 89.15% | $755.73 | $776.06 | $747.47 | -1.09% |
| Laboratory Corporation of America Holdings (LH) | 88.7% | $236.79 | $244.38 | $234.15 | -1.11% |
| Smith & Nephew (SNN) | 89.13% | $26.8 | $26.89 | $26.49 | -1.16% |
| Bristol (BMY) | 92.98% | $80.86 | $82.68 | $79.92 | -1.16% |
| Wausau Pape (WPP) | 89.36% | $52.4 | $52.8 | $51.79 | -1.16% |
| Genmab (GMAB) | 93.62% | $46.01 | $46.56 | $45.29 | -1.56% |
| Johnson & Johnson (JNJ) | 93.33% | $178.97 | $182.64 | $176.1 | -1.6% |
| Zoom (ZM) | 87.99% | $72.69 | $73.55 | $71.47 | -1.68% |
| Internationa Flavors & Fragrances (IFF) | 88.73% | $106.85 | $110.29 | $104.95 | -1.78% |
| Five9 (FIVN) | 93.41% | $66.13 | $68.73 | $64.43 | -2.57% |
| Ares Capital (ARCC) | 88.51% | $19.21 | $19.66 | $18.66 | -2.86% |
| Royal Caribbean Cruises (RCL) | 88.84% | $59.39 | $60.16 | $57.63 | -2.96% |
| Celanese (CE) | 88.17% | $108.49 | $109.67 | $104.81 | -3.39% |
| Live Nation Entertainment (LYV) | 88.57% | $73.75 | $75.11 | $70.91 | -3.85% |
1. Exelon (EXC)
Shares of Exelon jumped by a staggering 16.81% in from $36.65 to $42.81 at 21:29 EST on Tuesday, after two sequential sessions in a row of gains. NASDAQ is falling 2% to $11,014.89, after three consecutive sessions in a row of losses.
Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada.
Earnings Per Share
As for profitability, Exelon has a trailing twelve months EPS of $2.01.
PE Ratio
Exelon has a trailing twelve months price to earnings ratio of 21.3. Meaning, the purchaser of the share is investing $21.3 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.62%.Sales Growth
Exelon's sales growth is negative 56.6% for the ongoing quarter and 3.4% for the next.
Growth Estimates Quarters
The company's growth estimates for the ongoing quarter is a negative 50% and positive 3.1% for the next.Yearly Top and Bottom Value
Exelon's stock is valued at $42.81 at 21:29 EST, way under its 52-week high of $50.71 and way higher than its 52-week low of $35.19.
Volatility
Exelon's last week, last month's, and last quarter's current intraday variation average was 0.76%, 0.58%, and 1.67%.
Exelon's highest amplitude of average volatility was 1.14% (last week), 1.31% (last month), and 1.67% (last quarter).
More news about Exelon.
2. VALE (VALE)
Shares of VALE jumped by a staggering 20.72% in from $13.9 to $16.78 at 21:29 EST on Tuesday, after two successive sessions in a row of gains. NYSE is dropping 0.95% to $15,328.44, after two successive sessions in a row of losses.
Vale S.A., together with its subsidiaries, produces and sells iron ore and iron ore pellets for use as raw materials in steelmaking in Brazil and internationally.
Earnings Per Share
As for profitability, VALE has a trailing twelve months EPS of $2.02.
PE Ratio
VALE has a trailing twelve months price to earnings ratio of 8.32. Meaning, the purchaser of the share is investing $8.32 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 50.59%.Volume
Today's last reported volume for VALE is 20169200 which is 54.16% below its average volume of 44008400.
Yearly Top and Bottom Value
VALE's stock is valued at $16.78 at 21:29 EST, way under its 52-week high of $21.29 and way higher than its 52-week low of $11.16.
Volatility
VALE's last week, last month's, and last quarter's current intraday variation average was 2.49%, 0.87%, and 2.73%.
VALE's highest amplitude of average volatility was 2.49% (last week), 2.48% (last month), and 2.73% (last quarter).
More news about VALE.
3. White Mountains Insurance Group (WTM)
Shares of White Mountains Insurance Group dropped 1% in from $1324.17 to $1,310.93 at 21:29 EST on Tuesday, after five consecutive sessions in a row of losses. NYSE is dropping 0.95% to $15,328.44, after two consecutive sessions in a row of losses.
White Mountains Insurance Group, Ltd., through its subsidiaries, provides insurance and other financial services in the United States.
Earnings Per Share
As for profitability, White Mountains Insurance Group has a trailing twelve months EPS of $226.97.
PE Ratio
White Mountains Insurance Group has a trailing twelve months price to earnings ratio of 5.78. Meaning, the purchaser of the share is investing $5.78 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -5.78%.Revenue Growth
Year-on-year quarterly revenue growth grew by 95.8%, now sitting on 1.12B for the twelve trailing months.
More news about White Mountains Insurance Group.
4. Public Service Enterprise Group (PEG)
Shares of Public Service Enterprise Group rose 5.89% in from $57.21 to $60.58 at 21:29 EST on Tuesday, after two successive sessions in a row of gains. NYSE is falling 0.95% to $15,328.44, after two sequential sessions in a row of losses.
Public Service Enterprise Group Incorporated, through its subsidiaries, operates as an energy company primarily in the Northeastern and Mid-Atlantic United States.
Earnings Per Share
As for profitability, Public Service Enterprise Group has a trailing twelve months EPS of $3.76.
PE Ratio
Public Service Enterprise Group has a trailing twelve months price to earnings ratio of 16.11. Meaning, the purchaser of the share is investing $16.11 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -8.69%.Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Sep 7, 2022, the estimated forward annual dividend rate is 2.16 and the estimated forward annual dividend yield is 3.29%.
Moving Average
Public Service Enterprise Group's worth is above its 50-day moving average of $60.19 and under its 200-day moving average of $64.91.Volatility
Public Service Enterprise Group's last week, last month's, and last quarter's current intraday variation average was 1.10%, 0.22%, and 1.66%.
Public Service Enterprise Group's highest amplitude of average volatility was 1.27% (last week), 1.43% (last month), and 1.66% (last quarter).
More news about Public Service Enterprise Group.
5. Astrazeneca (AZN)
Shares of Astrazeneca jumped by a staggering 12.61% in from $61.04 to $68.74 at 21:29 EST on Tuesday, following the last session's upward trend. NYSE is dropping 0.95% to $15,328.44, after two successive sessions in a row of losses.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.
Earnings Per Share
As for profitability, Astrazeneca has a trailing twelve months EPS of $1.52.
PE Ratio
Astrazeneca has a trailing twelve months price to earnings ratio of 45.35. Meaning, the purchaser of the share is investing $45.35 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -4.84%.Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Astrazeneca's stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company's growth estimates for the current quarter is 33.3% and a drop 15.5% for the next.Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Aug 10, 2022, the estimated forward annual dividend rate is 1.45 and the estimated forward annual dividend yield is 2.52%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 31%, now sitting on 44.04B for the twelve trailing months.
More news about Astrazeneca.
6. Gilead Sciences (GILD)
Shares of Gilead Sciences rose 7.92% in from $81.46 to $87.91 at 21:29 EST on Tuesday, after two successive sessions in a row of losses. NASDAQ is dropping 2% to $11,014.89, after three sequential sessions in a row of losses.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Earnings Per Share
As for profitability, Gilead Sciences has a trailing twelve months EPS of $0.24.
PE Ratio
Gilead Sciences has a trailing twelve months price to earnings ratio of 366.29. Meaning, the purchaser of the share is investing $366.29 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.58%.More news about Gilead Sciences.
7. Church & Dwight Company (CHD)
Shares of Church & Dwight Company jumped by a staggering 10.42% in from $72.93 to $80.53 at 21:29 EST on Tuesday, after two consecutive sessions in a row of gains. NYSE is falling 0.95% to $15,328.44, after two sequential sessions in a row of losses.
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products.
Earnings Per Share
As for profitability, Church & Dwight Company has a trailing twelve months EPS of $3.08.
PE Ratio
Church & Dwight Company has a trailing twelve months price to earnings ratio of 26.14. Meaning, the purchaser of the share is investing $26.14 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.51%.Volatility
Church & Dwight Company's last week, last month's, and last quarter's current intraday variation average was 1.48%, 0.82%, and 1.16%.
Church & Dwight Company's highest amplitude of average volatility was 1.48% (last week), 0.99% (last month), and 1.16% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.2%, now sitting on 5.3B for the twelve trailing months.
Yearly Top and Bottom Value
Church & Dwight Company's stock is valued at $80.53 at 21:29 EST, way under its 52-week high of $105.28 and way above its 52-week low of $70.16.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Church & Dwight Company's stock is considered to be overbought (>=80).
More news about Church & Dwight Company.
8. NextEra Energy (NEE)
Shares of NextEra Energy jumped by a staggering 10.1% in from $77.36 to $85.17 at 21:29 EST on Tuesday, after two sequential sessions in a row of gains. NYSE is dropping 0.95% to $15,328.44, after two sequential sessions in a row of losses.
NextEra Energy, Inc., through its subsidiaries, generates, transmits, distributes, and sells electric power to retail and wholesale customers in North America.
Earnings Per Share
As for profitability, NextEra Energy has a trailing twelve months EPS of $2.11.
PE Ratio
NextEra Energy has a trailing twelve months price to earnings ratio of 40.36. Meaning, the purchaser of the share is investing $40.36 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.74%.Moving Average
NextEra Energy's worth is above its 50-day moving average of $80.90 and above its 200-day moving average of $79.55.Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,NextEra Energy's stock is considered to be oversold (<=20).
More news about NextEra Energy.
9. TJX Companies (TJX)
Shares of TJX Companies rose by a staggering 10.2% in from $72.14 to $79.50 at 21:29 EST on Tuesday, after four consecutive sessions in a row of losses. NYSE is dropping 0.95% to $15,328.44, after two consecutive sessions in a row of losses.
The TJX Companies, Inc., together with its subsidiaries, operates as an off-price apparel and home fashions retailer.
Earnings Per Share
As for profitability, TJX Companies has a trailing twelve months EPS of $0.07.
PE Ratio
TJX Companies has a trailing twelve months price to earnings ratio of 1135.71. Meaning, the purchaser of the share is investing $1135.71 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 56.86%.Moving Average
TJX Companies's value is way higher than its 50-day moving average of $65.52 and way above its 200-day moving average of $63.33.Volume
Today's last reported volume for TJX Companies is 3551900 which is 34.72% below its average volume of 5441610.
More news about TJX Companies.
10. Coca-Cola (KO)
Shares of Coca-Cola rose 6.68% in from $59.47 to $63.44 at 21:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, after two consecutive sessions in a row of losses.
The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide.
Earnings Per Share
As for profitability, Coca-Cola has a trailing twelve months EPS of $1.67.
PE Ratio
Coca-Cola has a trailing twelve months price to earnings ratio of 37.99. Meaning, the purchaser of the share is investing $37.99 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 41.03%.Volume
Today's last reported volume for Coca-Cola is 7682820 which is 46.77% below its average volume of 14434700.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.2%, now sitting on 42.34B for the twelve trailing months.
Yearly Top and Bottom Value
Coca-Cola's stock is valued at $63.44 at 21:29 EST, below its 52-week high of $67.20 and way higher than its 52-week low of $54.02.
More news about Coca-Cola.
11. Eli Lilly and Company (LLY)
Shares of Eli Lilly and Company rose 0.91% in from $365.15 to $368.47 at 21:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is sliding 0.95% to $15,328.44, after two consecutive sessions in a row of losses.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.68.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 55.16. Meaning, the purchaser of the share is investing $55.16 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 74.29%.More news about Eli Lilly and Company.
12. Booking Holdings (BKNG)
Shares of Booking Holdings rose by a staggering 10.86% in from $1840.36 to $2,040.22 at 21:29 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ is dropping 2% to $11,014.89, after three sequential sessions in a row of losses.
Booking Holdings Inc. provides travel and restaurant online reservation and related services worldwide.
Earnings Per Share
As for profitability, Booking Holdings has a trailing twelve months EPS of $1.44.
PE Ratio
Booking Holdings has a trailing twelve months price to earnings ratio of 1416.82. Meaning, the purchaser of the share is investing $1416.82 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 35.09%.Sales Growth
Booking Holdings's sales growth is 37.7% for the ongoing quarter and 31.1% for the next.
Yearly Top and Bottom Value
Booking Holdings's stock is valued at $2,040.22 at 21:29 EST, way below its 52-week high of $2,715.66 and way higher than its 52-week low of $1,616.85.
Volatility
Booking Holdings's last week, last month's, and last quarter's current intraday variation average was 1.25%, 0.57%, and 1.98%.
Booking Holdings's highest amplitude of average volatility was 1.72% (last week), 1.61% (last month), and 1.98% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 98.8%, now sitting on 14.65B for the twelve trailing months.
More news about Booking Holdings.
13. Ross Stores (ROST)
Shares of Ross Stores rose by a staggering 25.54% in from $93 to $116.75 at 21:29 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ is sliding 2% to $11,014.89, after three consecutive sessions in a row of losses.
Ross Stores, Inc., together with its subsidiaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dd's DISCOUNTS brand names.
Earnings Per Share
As for profitability, Ross Stores has a trailing twelve months EPS of $0.24.
PE Ratio
Ross Stores has a trailing twelve months price to earnings ratio of 486.44. Meaning, the purchaser of the share is investing $486.44 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.73%.Yearly Top and Bottom Value
Ross Stores's stock is valued at $116.75 at 21:29 EST, below its 52-week high of $119.48 and way higher than its 52-week low of $69.24.
Volume
Today's last reported volume for Ross Stores is 2080560 which is 23.39% below its average volume of 2716100.
Revenue growth
The year-over-year revenue growth was 4.6%. We now have 18.51B in the 12 trailing months.
Growth Estimates Quarters
The company's growth estimates for the present quarter and the next is 18.3% and 19.6%, respectively.More news about Ross Stores.
14. Boston Scientific (BSX)
Shares of Boston Scientific jumped 7.59% in from $41.92 to $45.10 at 21:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is dropping 0.95% to $15,328.44, after two sequential sessions in a row of losses.
Boston Scientific Corporation designs, manufactures and markets medical products for various medical specialty areas.
Earnings Per Share
As for profitability, Boston Scientific has a trailing twelve months EPS of $0.77.
PE Ratio
Boston Scientific has a trailing twelve months price to earnings ratio of 58.64. Meaning, the purchaser of the share is investing $58.64 for every dollar of annual earnings.
Moving Average
Boston Scientific is worth more than its moving average for 50 days of $41.67, and greater than its moving average for 200 days of $41.22.Sales Growth
Boston Scientific has experienced a 3.7% increase in sales for the current quarter, and 4.9% growth for the following.
More news about Boston Scientific.
15. Amicus Therapeutics (FOLD)
Shares of Amicus Therapeutics jumped by a staggering 18.74% in from $10.3 to $12.23 at 21:29 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ is dropping 2% to $11,014.89, after three successive sessions in a row of losses.
Amicus Therapeutics, Inc. is a biotechnology company that focuses on the discovery, development, and delivery of medicines for rare conditions.
Earnings per Share
Amicus Therapeutics' trailing 12 months profit per share is $-1.07.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a company relative to shareholders' equity, was negative at -145.09%.Sales Growth
Amicus Therapeutics's sales growth is 5.1% for the current quarter and 15.5% for the next.
Volume
The current reported volume at Amicus Therapeutics was 818298, which is 67.32% less than its usual volume of 2511990.
Moving Average
Amicus Therapeutics's value is much higher than its $50-day moving mean of $10.85, and far higher than its $200-day moving median of $9.86.More news about Amicus Therapeutics.
16. Merck (MRK)
Shares of Merck rose 8.71% in from $100.04 to $108.75 at 21:29 EST on Tuesday, after two sequential sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, after two successive sessions in a row of losses.
Merck & Co., Inc. operates as a healthcare company worldwide.
Earnings Per Share
As for profitability, Merck has a trailing twelve months EPS of $2.77.
PE Ratio
Merck has a trailing twelve months price to earnings ratio of 39.27. Meaning, the purchaser of the share is investing $39.27 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 43.42%.Volatility
Merck's intraday variation average for the week and quarter ended last week at 0.37%. 0.55% and 1.06% respectively.
Merck had the highest average volatility amplitude at 0.51%, 1.09% and 1.06% in last week.
Moving Average
Merck's worth is way above its 50-day moving average of $97.21 and way higher than its 200-day moving average of $89.50.More news about Merck.
17. Stryker Corp (SYK)
Shares of Stryker Corp jumped by a staggering 10.22% in from $213.17 to $234.96 at 21:29 EST on Tuesday, after four successive sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, after two successive sessions in a row of losses.
Stryker Corporation is a company that specializes in medical technology.
Earnings Per Share
As for profitability, Stryker Corp has a trailing twelve months EPS of $3.69.
PE Ratio
Stryker Corp has a trailing twelve months price to earnings ratio of 63.67. Meaning, the purchaser of the share is investing $63.67 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.1%.Classification of Stock Prices
The stochastic oscillator is a helpful indicator for overbought or oversold situations.Stryker Corp stock is overbought (>=80).
Growth Estimates Quarters
For the current quarter, the company expects to grow by 1.4% and 7.4% respectively.More news about Stryker Corp.
18. Regeneron Pharmaceuticals (REGN)
Shares of Regeneron Pharmaceuticals fell 0.55% in from $750.33 to $746.20 at 21:29 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ is falling 2% to $11,014.89, after three sequential sessions in a row of losses.
Regeneron Pharmaceuticals, Inc. develops, produces, markets, and distributes medications for various diseases around the world.
Earnings Per Share
As for profitability, Regeneron Pharmaceuticals has a trailing twelve months EPS of $30.52.
PE Ratio
Regeneron Pharmaceuticals has a trailing twelve months price to earnings ratio of 24.45. Meaning, the purchaser of the share is investing $24.45 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.76%.Volatility
Regeneron Pharmaceuticals's intraday variation average for the week and quarter ended December 31, 2013, 0.12% and 1.69 respectively.
Regeneron Pharmaceuticals had the highest average volatility amplitudes of 1.20%, 1.00% and 1.69% in the last week.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Regeneron Pharmaceuticals's stock is considered to be overbought (>=80).
More news about Regeneron Pharmaceuticals.
19. Laboratory Corporation of America Holdings (LH)
Shares of Laboratory Corporation of America Holdings rose 0.36% in from $233.78 to $234.62 at 21:29 EST on Tuesday, after five consecutive sessions in a row of losses. NYSE is sliding 0.95% to $15,328.44, after two sequential sessions in a row of losses.
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Earnings per Share
Laboratory Corporation of America Holdings' trailing 12 months profit per share was $26.89
PE Ratio
Laboratory Corporation of America Holdings' trailing 12 months earnings to price ratio is 8.72. The purchaser of the shares is therefore investing $8.72 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 19.26%.More news about Laboratory Corporation of America Holdings.
20. Smith & Nephew (SNN)
Shares of Smith & Nephew jumped 9.28% in from $24.24 to $26.49 at 21:29 EST on Tuesday, after four successive sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, after two consecutive sessions in a row of losses.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide.
Earnings Per Share
As for profitability, Smith & Nephew has a trailing twelve months EPS of $1.02.
PE Ratio
Smith & Nephew has a trailing twelve months price to earnings ratio of 25.87. Meaning, the purchaser of the share is investing $25.87 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.25%.Annual Top and Bottom Value
Smith & Nephew stock was valued at $26.49 as of 21:31 EST. This is way below its 52 week high of $37.05 but well above its 52 week low of $21.78.
Classification of Stock Prices
The stochastic oscillator is a helpful indicator for overbought or oversold situations.Smith & Nephew stock is overbought (>=80).
Volatility
Smith & Nephew last week's and last month's intraday variations averages were 1.09%, 0.49% and 1.55%, respectively.
Smith & Nephew had the highest amplitude average volatility, at 1.09% last week, 1.34% last month and 1.55% in quarter.
More news about Smith & Nephew.
21. Bristol (BMY)
Shares of Bristol rose 0.71% in from $79.26 to $79.82 at 21:29 EST on Tuesday, after four successive sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, after two successive sessions in a row of losses.
Bristol-Myers Squibb Company develops, licenses and manufactures biopharmaceutical product worldwide.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $-2.76.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.09%.Yearly Top and Bottom Value
Bristol's stock is valued at $79.82 at 21:31 EST, under its 52-week high of $80.59 and way above its 52-week low of $53.22.
Dividend Yield
According to Morningstar, Inc., there will be a next dividend payment on Jun 29, 2022. The forward dividend rate and forward dividend yield are both 2.16 and 2.93%, respectively.
More news about Bristol.
22. Wausau Pape (WPP)
Shares of Wausau Pape jumped by a staggering 11.96% in from $46.33 to $51.87 at 21:29 EST on Tuesday, after four sequential sessions in a row of losses. NYSE is dropping 0.95% to $15,328.44, after two successive sessions in a row of losses.
WPP plc is a company that creates transformation. It provides communication, experience, commerce and technology services throughout North America, North America and Western Continental Europe.
Earnings per Share
Wausau Pape's trailing 12 months EPS is $-16.87.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 15.81%.Revenue growth
The year-on-year revenue growth was 3.9%. 12.8B is the total for twelve months.
Moving Average
Wausau Pape's value is higher than its 50-day moving average of $47.46 and way under its 200-day moving average of $61.53.Volume
Today's last reported volume for Wausau Pape is 98523 which is 31.25% below its average volume of 143323.
More news about Wausau Pape.
23. Genmab (GMAB)
Shares of Genmab rose by a staggering 14.36% in from $39.7 to $45.40 at 21:29 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ is sliding 2% to $11,014.89, after three successive sessions in a row of losses.
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark.
Earnings Per Share
As for profitability, Genmab has a trailing twelve months EPS of $0.66.
PE Ratio
Genmab has a trailing twelve months price to earnings ratio of 68.67. Meaning, the purchaser of the share is investing $68.67 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.71%.Sales Growth
Genmab has experienced a 26.8% increase in sales for its current quarter, and 31.8% growth for the next.
More news about Genmab.
24. Johnson & Johnson (JNJ)
Shares of Johnson & Johnson rose 1.75% in from $172.98 to $176.01 at 21:29 EST on Tuesday, after two sequential sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, after two sequential sessions in a row of losses.
Johnson & Johnson and its affiliates research, develop, produce, and market various healthcare products around the world.
Earnings per Share
Johnson & Johnson's trailing 12 months EPS is $5.66.
PE Ratio
Johnson & Johnson's trailing 12 months earnings to price ratio is 31.09. The purchaser of the shares is therefore investing $31.09 per dollar in annual earnings.
Growth Estimates Quarters
The company's growth estimates for the current quarter is 4.7% and a drop 3.7% for the next.Yearly Top and Bottom Value
Johnson & Johnson's stock is valued at $176.01 at 21:32 EST, under its 52-week high of $186.69 and way higher than its 52-week low of $155.72.
Volume
Today's last reported volume for Johnson & Johnson is 5242430 which is 25.37% below its average volume of 7025380.
More news about Johnson & Johnson.
25. Zoom (ZM)
Shares of Zoom dropped by a staggering 12.12% in from $81.3 to $71.45 at 21:29 EST on Tuesday, after five successive sessions in a row of losses. NASDAQ is dropping 2% to $11,014.89, after three consecutive sessions in a row of losses.
Zoom Video Communications, Inc. offers unified communication platform for the Americas, Asia Pacific, Europe, Middle East, Middle East, Africa.
Earnings per Share
Zoom's trailing twelve-month EPS is $2.25.
PE Ratio
Zoom's trailing 12 months earnings to price ratio is 31.73 The purchaser of the shares is therefore investing $31.73 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a company relative to shareholders' equity, was 24.89%.Growth Estimates Quarters
For the current quarter, the company expects to grow by a negative 31.6%. The next quarter will see a negative 18.9%.More news about Zoom.
26. Internationa Flavors & Fragrances (IFF)
Shares of Internationa Flavors & Fragrances jumped 9.14% in from $96.11 to $104.89 at 21:29 EST on Tuesday, after two consecutive sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, after two sequential sessions in a row of losses.
International Flavors & Fragrances Inc. and its subsidiaries manufacture and sell cosmetic actives and natural health ingredients that can be used in various consumer products throughout Europe, Africa and the Middle East.
Earnings Per Share
As for profitability, Internationa Flavors & Fragrances has a trailing twelve months EPS of $3.21.
PE Ratio
Internationa Flavors & Fragrances has a trailing twelve months price to earnings ratio of 32.68. Meaning, the purchaser of the share is investing $32.68 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.05%.Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Internationa Flavors & Fragrances's stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
Internationa Flavors & Fragrances's stock is valued at $104.89 at 21:33 EST, way under its 52-week high of $151.86 and way higher than its 52-week low of $83.14.
Volume
Internationa Flavors & Fragrances' last reported volume is now 1586420, which is 11.8% lower than its average volume (1792190).
More news about Internationa Flavors & Fragrances.
27. Five9 (FIVN)
Shares of Five9 jumped by a staggering 36.66% in from $47 to $64.23 at 21:29 EST on Tuesday, after two successive sessions in a row of losses. NASDAQ is dropping 2% to $11,014.89, after three successive sessions in a row of losses.
Five9, Inc. and its subsidiaries provide cloud software to contact centers across the United States as well as internationally.
Earnings per Share
For profitability, Five9's trailing 12 months EPS is $-0.72.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was negative at -40.2%.More news about Five9.
28. Ares Capital (ARCC)
Shares of Ares Capital dropped 5.84% in from $19.81 to $18.65 at 21:29 EST on Tuesday, after four sequential sessions in a row of losses. NASDAQ is sliding 2% to $11,014.89, after three consecutive sessions in a row of losses.
Ares Capital Corporation, a business development firm, specializes in the acquisition, recapitalization and restructuring of middle-market companies.
Earnings Per Share
As for profitability, Ares Capital has a trailing twelve months EPS of $3.46.
PE Ratio
Ares Capital has a trailing twelve months price to earnings ratio of 5.39. Meaning, the purchaser of the share is investing $5.39 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.92%.Sales Growth
Ares Capital's sales growth is 12.9% for the current quarter and negative 23.5% for the next.
Moving Average
Ares Capital's value is below its 50-day moving average of $19.42 and under its 200-day moving average of $20.13.Revenue Growth
Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 1.89B for the twelve trailing months.
Volume
The last volume reported by Ares Capital was 4999880, which is 79.62% higher than its average volume (2783510).
More news about Ares Capital.
29. Royal Caribbean Cruises (RCL)
Shares of Royal Caribbean Cruises rose by a staggering 10.57% in from $52.05 to $57.55 at 21:29 EST on Tuesday, after five successive sessions in a row of losses. NYSE is dropping 0.95% to $15,328.44, after two sequential sessions in a row of losses.
Royal Caribbean Cruises Ltd.
Earnings per Share
Royal Caribbean Cruises' trailing 12 months profit per share is $-24.62
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was negative at -79.25%.Sales Growth
Royal Caribbean Cruises's sales growth is 565.1% for the current quarter and 175.3% for the next.
Volume
Today's last reported volume for Royal Caribbean Cruises is 4174090 which is 39.09% below its average volume of 6853790.
Volatility
Royal Caribbean Cruises's last week, last month's, and last quarter's current intraday variation average was 1.38%, 0.58%, and 3.55%.
Royal Caribbean Cruises's highest amplitude of average volatility was 1.82% (last week), 2.54% (last month), and 3.55% (last quarter).
More news about Royal Caribbean Cruises.
30. Celanese (CE)
Shares of Celanese rose by a staggering 13.89% in from $92.01 to $104.79 at 21:29 EST on Tuesday, after two consecutive sessions in a row of losses. NYSE is falling 0.95% to $15,328.44, after two consecutive sessions in a row of losses.
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally.
Earnings per Share
Celanese's trailing 12 months profit per share is $17.84
PE Ratio
Celanese's trailing 12-month price-earnings ratio is 5.87. The purchaser of the shares is investing $5.87 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 42.55%.Volume
The last recorded volume of Celanese was 860354, which is 25% lower than its average volume (1161740).
Sales Growth
The quarter ahead of Celanese is expected to see a negative 7.4% sales growth.
Volatility
Celanese's last week, last month's, and last quarter's current intraday variation average was 2.02%, 0.82%, and 2.55%.
Celanese's highest amplitude of average volatility was 2.02% (last week), 2.79% (last month), and 2.55% (last quarter).
More news about Celanese.
31. Live Nation Entertainment (LYV)
Shares of Live Nation Entertainment fell 3.27% in from $73.31 to $70.91 at 21:29 EST on Tuesday, after two sequential sessions in a row of losses. NYSE is sliding 0.95% to $15,328.44, after two successive sessions in a row of losses.
Live Nation Entertainment, Inc. is a live entertainment business.
Earnings per Share
Live Nation Entertainment's trailing 12 months profit per share was $-8.12.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 76.57%.More news about Live Nation Entertainment.